Patents by Inventor Jaume Sangra Perez

Jaume Sangra Perez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION OF OMEPRAZOLE
    Publication number: 20140255503
    Abstract: The present invention refers to oral solid pharmaceutical compositions comprising concentrate omeprazole pellets, processes for the preparation of the same and their use as medicaments, more particularly for the treatment and/or prophylaxis of a gastrointestinal disorder.
    Type: Application
    Filed: October 31, 2012
    Publication date: September 11, 2014
    Inventors: Jaume Sangrà Perez, Cristina Alcocer Aranzana
  • Tableted oral pharmaceutical dosage form, with enteric coating, containing a compound of benzimidazole labile in an acid medium
    Patent number: 7217429
    Abstract: The pharmaceutical dosage form consists of a plurality of units containing a benzimidazole compound labile in an acid medium as the active principle, each unit being comprised of an inert core, a layer containing the active principle and an intermediate layer. These units, mixed with compression excipients, compressed and coated with an enteric coating, provide a tableted pharmaceutical dosage form suitable for oral administration for preventing and treating disorders related to abnormal secretion of gastric acid.
    Type: Grant
    Filed: December 12, 2002
    Date of Patent: May 15, 2007
    Inventors: Javier Lizcano Garcia, Jaume Sangra Perez, Pere Joan Solanas Ibarra, Antonio Lopez Cabrera
  • Tableted oral pharmaceutical dosage form, with enteric coating, containing a compound of benzimidazole labile in an acid medium
    Publication number: 20030118650
    Abstract: The pharmaceutical dosage form consists of a plurality of units containing a benzimidazole compound labile in an acid medium as the active principle, each unit being comprised of an inert core, a layer containing the active principle and an intermediate layer. These units, mixed with compression excipients, compressed and coated with an enteric coating, provide a tableted pharmaceutical dosage form suitable for oral administration for preventing and treating disorders related to abnormal secretion of gastric acid.
    Type: Application
    Filed: December 12, 2002
    Publication date: June 26, 2003
    Inventors: Javier Lizcano Garcia, Jaume Sangra Perez, Pere Joan Solanas Ibarra, Antonio Lopez Cabrera